Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients. This evidence concerns the gene DPP4 and obesity due to melanocortin 4 receptor deficiency.